about
Retinopathy of prematurity: current concepts in molecular pathogenesis.Analysis of patient outcomes following proton radiation therapy for retinoblastoma.Abnormal white matter tractography of visual pathways detected by high-angular-resolution diffusion imaging (HARDI) corresponds to visual dysfunction in cortical/cerebral visual impairment.Characterizing Visual Field Deficits in Cerebral/Cortical Visual Impairment (CVI) Using Combined Diffusion Based Imaging and Functional Retinotopic Mapping: A Case Study.Use of optical coherence tomography to evaluate papilledema and pseudopapilledema.Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature.Update on the evaluation of pediatric idiopathic intracranial hypertension.Congenital optic nerve anomalies and hereditary optic neuropathies.Evaluation and Management of Acute Acquired Comitant Esotropia in Children.Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care.Visual outcomes in pediatric optic neuritis.Pediatric Idiopathic Intracranial Hypertension: Age, Gender, and Anthropometric Features at Diagnosis in a Large, Retrospective, Multisite Cohort.Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.Using spectral-domain optical coherence tomography to detect optic neuropathy in patients with craniosynostosis.Morning glory disc anomaly: characteristic MR imaging findings.Optic nerve appearance in patients with Down syndrome.Visual and ocular motor outcomes in children with posterior fossa tumors.Identification and characterization of the Drosophila tau homolog.Reply: To PMID 24907434.Neuro-Ophthalmic Manifestations of Pediatric Neurodegenerative Disease.Congenital Fibrosis of the Extraocular MusclesNeuroimaging Findings in Patients With Down Syndrome and NystagmusVisual Field Testing in Pediatric PatientsRadiographic features in pediatric idiopathic intracranial hypertensionVisual field outcomes in children with neurofibromatosis type 1 associated optic pathway gliomasEvaluation and Management of Optic Pathway GliomasPediatric spectral domain optical coherence tomography (SD-OCT) normative data for novel optic nerve parameters using the Heidelberg SpectralisThe impact of brain tumors on vision and ocular motilityNoninvasive assessment of intracranial pressure using otoacoustic emissions in pediatric patients with idiopathic intracranial hypertension (IIH)Optic nerve volumetric measurements in pediatric papilledema with spectral domain OCTUsing spectral-domain optical coherence tomography to monitor optic neuropathy in patients with craniosynostosisUtilization of MRV to evaluate pediatric patients with papilledemaVisual outcomes in pediatric optic neuritisAAP/AAPOS pediatric neuro-ophthalmology workshop: Avoiding disaster—lessons learned from difficult casesAsymptomatic pediatric idiopathic intracranial hypertensionThe Genetics of Strabismus and Associated DisordersRelationship between the timing of cataract surgery and development of nystagmus in patients with bilateral infantile cataractsCourse of nystagmus in patients with bilateral infantile cataractsPediatric open-globe injuries: A large-scale, retrospective reviewSurgical Management in Congenital Fibrosis of the Extraocular Muscles
P50
Q33606227-87C34EC6-AB66-47CF-AFBD-9FEBB3B5021CQ33782262-F13B721B-4208-4B8F-8FE0-C4121130F1FFQ34115662-C6A8FB05-311E-45C7-995F-E76A95920050Q36615261-3079BFF3-42F8-4E65-A351-8A96B2A8E016Q37810926-3D5207CF-6B97-42D0-A26D-E245B963BAF0Q38166902-3AE81351-ACC1-4EDD-AC09-57E57D57CA7BQ38943908-B3E48AF1-8871-4D4F-9CE2-A3CAE13CE916Q38954004-D8108CE8-D13E-49C8-BBC6-BC01AFD16F34Q38977585-DD685751-A7D6-4E87-8E23-6B1365BB1546Q39000307-32BDA03E-1CC2-4C34-9334-95216C6ECF94Q39179177-1137F328-109F-40B8-9D6B-D8356FC82247Q39332968-5B989629-FA14-42F6-A706-72D3F8A62ABFQ39677669-F02AE7ED-EE30-41AE-98C3-623EA8F56F78Q41700961-5778679F-936B-4DC1-99C2-C0EA7AA76271Q43905851-C33C3AE4-72A6-4593-812F-91DBB8D68CCFQ44584848-E26AA2D0-5D9B-437D-9C3C-6BFFF125FF68Q47257074-7A94CD93-E86A-4A15-9437-DA0036100109Q48340828-B5C2C91E-E604-4B60-A724-2D3D2A7B981AQ48674472-2E57B5DD-E412-4961-AB26-038E5BB7B7A1Q52544369-2EBB59DD-A66D-446C-872D-6E80ED2035F1Q57252234-EF3ECE22-3B54-4B46-845B-EE6F7DD461F6Q58920676-225FA3B7-DDD9-40A7-8F97-69BA3DCF1A30Q58920688-88F0142C-5D13-4BA1-B7C8-AC4241AE891EQ58920693-937D5ABD-DC98-46CE-BC7A-42B65A561C3AQ58920698-0C38BB0B-6F4E-4A70-AB41-D28D7016DF2BQ58920710-B5832F7B-6329-4368-99F0-862DC83FBCC6Q58920718-7228212E-79D7-4E8D-A0F5-8DD5831AD2B1Q58920726-3279B874-670B-4C26-9036-7F1EAB0B55D1Q58920749-80DE1A25-26CD-4041-9E5B-29753FA8C786Q58920759-C3054092-5852-4976-9136-585909B08E01Q58920767-C31FD455-D954-4C4C-B5F7-F4D82C7EF886Q58920772-EE272A44-ECCE-4003-AFDB-47863EE5D298Q58920776-A93B84B4-4A3B-4809-9A8A-99D36B831338Q58920792-1AC8AEAC-BA80-4DEC-8012-39ACAE7CD381Q58920801-629237B6-7AC9-4957-9896-FCA431B1349DQ58920816-4B9001C8-F6CC-45B9-B654-C6C20DE26971Q58920821-F821E878-270A-4777-9CE6-7689571084C1Q58920824-5633FDDD-7DA3-4FAD-96DA-E5389B7179ABQ58920827-5F32158D-64B0-421D-A170-F75759749A3DQ58920842-0B14B54C-F2BC-4F19-9337-82D094F61020
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gena Heidary
@ast
Gena Heidary
@en
Gena Heidary
@es
Gena Heidary
@nl
Gena Heidary
@sl
type
label
Gena Heidary
@ast
Gena Heidary
@en
Gena Heidary
@es
Gena Heidary
@nl
Gena Heidary
@sl
prefLabel
Gena Heidary
@ast
Gena Heidary
@en
Gena Heidary
@es
Gena Heidary
@nl
Gena Heidary
@sl
P106
P21
P31
P496
0000-0002-3557-0420